For the Inventor, By the Inventor

Enter assignee name

Miami, FL, United States of America

Opko Health, Inc.

Patents = 26

Trademarks = 1

Forward Citations = 155

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

91 inventors (with patents filed for the assignee):

Sunil Paliwal (15 out of 28 patents)

Neng-Yang Shih (15 out of 110 patents)

Hon-Chung Tsui (12 out of 19 patents)

4. Dong Xiao (9 out of 41 patents)

5. Anandan Palani (9 out of 70 patents)

6. Michelle Laci Wrobleski (9 out of 12 patents)

7. Cheng Wang (9 out of 26 patents)

8. Ingrid Mergelsberg (8 out of 8 patents)

9. Xianhai Huang (5 out of 49 patents)

10. Sapna S Shah (5 out of 6 patents)

11. Ashwin Umesh Rao (5 out of 19 patents)

12. Gregory A Reichard (4 out of 21 patents)

13. Juan D Arredondo (4 out of 5 patents)

14. Zhihui Qiu (4 out of 7 patents)

15. Mengwei Hu (3 out of 4 patents)

26 patents: Sort by Forward Citations

1. 10196394 - Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor (2019-02-05),

2. 10000493 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2018-06-19),

3. 9969711 - [object Object] (2018-05-15),

4. 9822116 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2017-11-21),

5. 9688693 - [object Object] (2017-06-27),

6. 9551721 - Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases (2017-01-24),

7. 9469629 - [object Object] (2016-10-18),

8. 9345692 - Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same (2016-05-24),

9. 9260428 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2016-02-16),

10. 9249144 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2016-02-02),

11. 9101615 - Intravenous formulations of neurokinin-1 antagonists (2015-08-11),

12. 9006211 - Hypersulfated disaccharide formulations (2015-04-14),

13. 8906410 - Oral dosage form of 25-hydroxyvitamin D (2014-12-09),

14. 8796299 - NK1 antagonists (2014-08-05),

15. 8754216 - NK1 antagonists (2014-06-17),

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. It operates through four segments: BioReference Laboratories, RAYALDEE, Pharmaceutical Therapeutics, and Other. The company develops and commercializes innovative products and solutions in various areas, including diagnostics, therapeutics, and pharmaceuticals. OPKO Health's mission is to improve patient health and well-being through cutting-edge technology and advanced research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

26 Patents

#23 in Miami, FL

#313 in Florida

#12,424 in US

#24,048 in the World

Miami, FL, United States of America

Opko Health, Inc.

Forward Citations = 155

91 inventors:

Sunil Paliwal (15 out of 28 patents)

Neng-Yang Shih (15 out of 110 patents)

Hon-Chung Tsui (12 out of 19 patents)

4. Dong Xiao (9 out of 41 patents)

5. Anandan Palani (9 out of 70 patents)

Please report any incorrect information to support@idiyas.com

Loading…